These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103. Revisiting the SAR of the Antischistosomal Aryl Hydantoin (Ro 13-3978). Wang C; Zhao Q; Vargas M; Jones JO; White KL; Shackleford DM; Chen G; Saunders J; Ng AC; Chiu FC; Dong Y; Charman SA; Keiser J; Vennerstrom JL J Med Chem; 2016 Dec; 59(23):10705-10718. PubMed ID: 27933964 [TBL] [Abstract][Full Text] [Related]
104. The discovery of a novel series of compounds with single-dose efficacy against juvenile and adult Schistosoma species. Gardner JMF; Mansour NR; Bell AS; Helmby H; Bickle Q PLoS Negl Trop Dis; 2021 Jul; 15(7):e0009490. PubMed ID: 34280206 [TBL] [Abstract][Full Text] [Related]
105. In vitro and in vivo antischistosomal activity of ferroquine derivatives. Keiser J; Vargas M; Rubbiani R; Gasser G; Biot C Parasit Vectors; 2014 Sep; 7():424. PubMed ID: 25190030 [TBL] [Abstract][Full Text] [Related]
106. In vivo schistosomicidal activity of 7-epiclusianone and its quantification in the plasma of healthy and Schistosoma mansoni infected mice using UPLC-MS/MS. Castro AP; Kawano T; Spelta LEW; de Castro AT; Pereira NA; Couto FFB; Dos Santos MH; Boralli VB; Marques MJ Phytomedicine; 2018 Jan; 38():66-73. PubMed ID: 29425656 [TBL] [Abstract][Full Text] [Related]
107. Addressing the oxamniquine in vitro-in vivo paradox to facilitate a new generation of anti-schistosome treatments. Toth K; Alwan S; Khan S; McHardy SF; LoVerde PT; Cameron MD Int J Parasitol Drugs Drug Resist; 2023 Apr; 21():65-73. PubMed ID: 36758271 [TBL] [Abstract][Full Text] [Related]
108. Impedance-Based Microfluidic Assay for Automated Antischistosomal Drug Screening. Chawla K; Modena MM; Ravaynia PS; Lombardo FC; Leonhardt M; Panic G; Bürgel SC; Keiser J; Hierlemann A ACS Sens; 2018 Dec; 3(12):2613-2620. PubMed ID: 30426744 [TBL] [Abstract][Full Text] [Related]
109. Synthesis, in vitro schistosomicidal activity and ultrastructural alterations caused by thiosemicarbazones and thiazolidinones against juvenile and adult Schistosoma mansoni worms (Sambon, 1907). Tavares da Rocha RE; de Almeida Júnior ASA; Júnior NCP; do Nascimento AV; Leite NMS; de Oliveira JF; Alves de Lima MDC; Feitosa APS; Bezerra de Mélo ME; Brayner FA; Alves LC Mol Biochem Parasitol; 2022 Nov; 252():111520. PubMed ID: 36122704 [TBL] [Abstract][Full Text] [Related]
110. Mitochondria as a Potential Target for the Development of Prophylactic and Therapeutic Drugs against Schistosoma mansoni Infection. Talaam KK; Inaoka DK; Hatta T; Tsubokawa D; Tsuji N; Wada M; Saimoto H; Kita K; Hamano S Antimicrob Agents Chemother; 2021 Sep; 65(10):e0041821. PubMed ID: 34339272 [TBL] [Abstract][Full Text] [Related]
111. Drug Discovery and Target Identification against Schistosomiasis: A Reality Check on Progress and Future Prospects. Cheuka PM Curr Top Med Chem; 2022; 22(19):1595-1610. PubMed ID: 34565320 [TBL] [Abstract][Full Text] [Related]
112. The anticancer drug imatinib induces autophagy in Schistosoma mansoni. Mughal MN; Grevelding CG; Haeberlein S Int J Parasitol; 2022 Mar; 52(4):211-215. PubMed ID: 34838573 [TBL] [Abstract][Full Text] [Related]
113. Development of Praziquantel sulphonamide derivatives as antischistosomal drugs. Angeli A; Ferraroni M; Carta F; Häberli C; Keiser J; Costantino G; Supuran CT J Enzyme Inhib Med Chem; 2022 Dec; 37(1):1479-1494. PubMed ID: 35635137 [TBL] [Abstract][Full Text] [Related]
114. Whole-genome sequencing of Schistosoma mansoni reveals extensive diversity with limited selection despite mass drug administration. Berger DJ; Crellen T; Lamberton PHL; Allan F; Tracey A; Noonan JD; Kabatereine NB; Tukahebwa EM; Adriko M; Holroyd N; Webster JP; Berriman M; Cotton JA Nat Commun; 2021 Aug; 12(1):4776. PubMed ID: 34362894 [TBL] [Abstract][Full Text] [Related]
115. Rational approach to drug discovery for human schistosomiasis. LoVerde PT; Alwan SN; Taylor AB; Rhodes J; Chevalier FD; Anderson TJ; McHardy SF Int J Parasitol Drugs Drug Resist; 2021 Aug; 16():140-147. PubMed ID: 34111649 [TBL] [Abstract][Full Text] [Related]
116. Activities of N,N'-Diarylurea MMV665852 analogs against Schistosoma mansoni. Cowan N; Dätwyler P; Ernst B; Wang C; Vennerstrom JL; Spangenberg T; Keiser J Antimicrob Agents Chemother; 2015 Apr; 59(4):1935-41. PubMed ID: 25583726 [TBL] [Abstract][Full Text] [Related]
117. In vivo schistosomicidal activity of (±)-licarin A-loaded poly(ε-caprolactone) nanoparticles. Lima TC; Magalhães LG; de L Paula LA; Cunha WR; Januário AH; Pauletti PM; Bastos JK; Mnuquian HA; Forim MR; Morais-Urano RP; Laurentiz RS; Tondato WN; Molina EF; Santos MFC; E Silva MLA Exp Parasitol; 2022 Oct; 241():108357. PubMed ID: 35998724 [TBL] [Abstract][Full Text] [Related]
118. Repurposing of anticancer drugs: in vitro and in vivo activities against Schistosoma mansoni. Cowan N; Keiser J Parasit Vectors; 2015 Aug; 8():417. PubMed ID: 26265386 [TBL] [Abstract][Full Text] [Related]
119. Improving translational power in antischistosomal drug discovery. Probst A; Biendl S; Keiser J Adv Parasitol; 2022; 117():47-73. PubMed ID: 35878949 [TBL] [Abstract][Full Text] [Related]